Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity ▴	Revenue growth	Diluted EPS
CTNM	Contineum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$59.98M	n/a	-23.0%	n/a	-$2.17
ELVN	Enliven Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$103.69M	n/a	-22.6%	n/a	-$1.83
ORKA	Oruka Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$105.43M	n/a	-22.3%	n/a	n/a
TVTX	Travere Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$490.73M	-$25.55M	-5.2%	-22.2%	110.5%	-$0.29
VREOF	Vireo Growth Inc. Manufacturing · Year ended 2025-12-31 · USD	$268.77M	-$68.11M	-25.3%	-22.2%	170.4%	-$0.09
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
PTGX	Protagonist Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$46.02M	-$130.15M	-282.8%	-21.2%	-89.4%	-$2.05
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
MBIO	Mustang Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.92M	n/a	-20.2%	n/a	-$0.39
ARVN	Arvinas, Inc. Manufacturing · Year ended 2025-12-31 · USD	$262.60M	-$80.80M	-30.8%	-18.6%	-0.3%	-$1.14
OPK	Opko Health, Inc. Manufacturing · Year ended 2025-12-31 · USD	$606.88M	-$225.68M	-37.2%	-17.8%	-14.9%	-$0.30
LAB	Standard Biotools Inc. Manufacturing · Year ended 2025-12-31 · USD	$85.33M	-$74.90M	-87.8%	-17.7%	-6.2%	-$0.20
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
CTMX	CytomX Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$76.20M	-$17.37M	-22.8%	-17.5%	-44.8%	n/a
SCYX	Scynexis Inc Manufacturing · Year ended 2025-12-31 · USD	$20.60M	-$8.61M	-41.8%	-17.4%	449.9%	-$0.17
AKBA	Akebia Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$236.20M	-$5.34M	-2.3%	-16.4%	47.5%	-$0.02
INBP	Integrated Biopharma Inc Manufacturing · Year ended 2026-06-30 · USD	$43.87M	-$2.84M	-6.5%	-16.1%	-19.3%	-$0.09
RLYB	Rallybio Corp Manufacturing · Year ended 2025-12-31 · USD	$858.0K	-$8.98M	n/m	-15.5%	34.9%	-$1.59
ABCL	AbCellera Biologics Inc. Manufacturing · Year ended 2025-12-31 · USD	$75.13M	-$146.41M	-194.9%	-15.1%	160.6%	-$0.49
WHWK	Whitehawk Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.14M	-$20.60M	-288.3%	-15.1%	-72.5%	-$0.33
XNCR	Xencor Inc Manufacturing · Year ended 2025-12-31 · USD	$125.58M	-$91.92M	-73.2%	-14.5%	13.7%	-$1.24
RMTI	Rockwell Medical, Inc. Manufacturing · Year ended 2025-12-31 · USD	$69.26M	-$5.31M	-7.7%	-14.4%	-31.8%	-$0.15
CPHI	China Pharma Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.14M	-$3.19M	-76.9%	-14.0%	-8.5%	-$0.74
OVID	Ovid Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.25M	-$17.41M	-240.1%	-13.3%	n/m	n/a

Rows per page: 2550 100